<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-18889" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Cardiac Fibroma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rajput</surname>
            <given-names>Furqan A.</given-names>
          </name>
          <aff>University of Wisconsin - Madison</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bishop</surname>
            <given-names>Michael A.</given-names>
          </name>
          <aff>Mercy St. Vincent Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Alahmadi</surname>
            <given-names>Mohamed H.</given-names>
          </name>
          <aff>University of Health Sciences, Lahore</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Limaiem</surname>
            <given-names>Faten</given-names>
          </name>
          <aff>University of Tunis El Manar, Tunis Faculty of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Furqan Rajput declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Bishop declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mohamed Alahmadi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Faten Limaiem declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>30</day>
          <month>4</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-18889.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Cardiac fibromas, the second most common primary cardiac tumor in children after rhabdomyoma, are characterized by their composition of connective tissue and fibroblasts. Despite their benign nature, they can present symptomatic challenges such as intracavitary obstruction, coronary artery compromise, and conduction defects, which may lead to sudden death. Pediatric cardiac tumors often coincide with genetic conditions, exemplified by the association of rhabdomyoma with tuberous sclerosis and the presence of cardiac fibromas in 3% to 5% of patients with nevoid basal cell carcinoma syndrome, also known as Gorlin or Gorlin-Goltz syndrome.</p>
        <p>This continuing education activity provides an in-depth review of the diagnostic workup for cardiac fibromas. Clinicians enhance their understanding of this condition and optimize patient care by exploring the various imaging modalities and treatment options available. Further, this activity emphasizes the importance of a collaborative approach among healthcare professionals in managing cardiac fibroma cases. Through interdisciplinary coordination, including dermatologists, pediatricians, geneticists, and cardiologists, healthcare teams can provide comprehensive care tailored to each patient's unique needs, ultimately improving outcomes for individuals affected by cardiac fibromas.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Differentiate cardiac fibromas from other cardiac tumors and nonneoplastic conditions based on clinical presentation and diagnostic findings.</p></list-item><list-item><p>Screen high-risk populations, such as individuals with genetic syndromes associated with cardiac fibromas, for early detection and intervention.</p></list-item><list-item><p>Implement evidence-based management strategies tailored to patients' needs and clinical presentation, including surgical resection and medical therapy.</p></list-item><list-item><p>Collaborate with healthcare teams to develop coordinated care plans and ensure continuity of care throughout the patient's treatment journey.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18889&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18889">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-18889.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Primary cardiac tumors are rare, having a reported incidence of 0.03% to 0.32%; 75% of these tumors are benign.<xref ref-type="bibr" rid="article-18889.r1">[1]</xref><xref ref-type="bibr" rid="article-18889.r2">[2]</xref><xref ref-type="bibr" rid="article-18889.r3">[3]</xref><xref ref-type="bibr" rid="article-18889.r4">[4]</xref>&#x000a0;Among children, cardiac fibromas rank as the second most common primary cardiac tumor&#x000a0;after rhabdomyoma. Cardiac rhabdomyomas and fibromas&#x000a0;are classified&#x000a0;within the subset of nonneoplastic hamartomas. Composed primarily of connective tissue and fibroblasts, cardiac fibromas, although benign, can manifest symptoms due to intracavitary obstruction, inflow and outflow tract obstruction, coronary artery compromise, thromboembolic events, conduction defects, and can even lead to sudden death.<xref ref-type="bibr" rid="article-18889.r4">[4]</xref><xref ref-type="bibr" rid="article-18889.r5">[5]</xref><xref ref-type="bibr" rid="article-18889.r6">[6]</xref>&#x000a0;Pediatric cardiac tumors often coincide with genetic conditions. For instance, rhabdomyoma is associated with tuberous sclerosis, while approximately 3% to 5% of patients with nevoid basal cell carcinoma syndrome, also known as Gorlin or Gorlin-Goltz syndrome, present with cardiac fibromas.<xref ref-type="bibr" rid="article-18889.r7">[7]</xref><xref ref-type="bibr" rid="article-18889.r8">[8]</xref></p>
      </sec>
      <sec id="article-18889.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Cardiac fibroma is a medical condition associated with Gorlin-Goltz syndrome, also known as nevoid basal cell carcinoma syndrome. However, most patients with cardiac fibroma do not&#x000a0;exhibit the complete expression of this genetic disorder. Gorlin-Goltz syndrome is an autosomal dominant, multisystem disorder caused by mutations in the&#x000a0;<italic toggle="yes">PTCH1</italic> or&#x000a0;<italic toggle="yes">SUFU</italic> tumor suppressor genes&#x000a0;located at chromosome 9q22.3. These genes produce a protein that suppresses tumor growth by inhibiting the Hedgehog signaling pathway. Gorlin-Goltz syndrome is estimated to have a prevalence of&#x000a0;1 in 57,000 to 1 in 164,000, with a man-to-woman ratio of 1:1 and an incidence rate of 1 in 19,000 live births.<xref ref-type="bibr" rid="article-18889.r9">[9]</xref><xref ref-type="bibr" rid="article-18889.r10">[10]</xref> As an autosomal dominant disease, this condition is&#x000a0;typically inherited from an affected parent but can also&#x000a0;occur de novo in 20% to 30% of cases.<xref ref-type="bibr" rid="article-18889.r11">[11]</xref></p>
      </sec>
      <sec id="article-18889.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>According to the World Health Organization (WHO) 2021 classification, cardiac fibroma primarily affects children, accounting for approximately 90% of cases.<xref ref-type="bibr" rid="article-18889.r12">[12]</xref> Most cases are detected either in infants or in utero. While cardiac fibromas typically present in infancy before the first year of life, in&#x000a0;individuals with nevoid basal cell carcinoma syndrome, they have&#x000a0;been reported to develop up to age 60.<xref ref-type="bibr" rid="article-18889.r13">[13]</xref><xref ref-type="bibr" rid="article-18889.r14">[14]</xref>&#x000a0;Cardiac fibromas&#x000a0;are the second most common benign cardiac tumor in children, following rhabdomyoma. They are also frequently detected as the second most common tumor in fetuses, often due to prenatal diagnosis.<xref ref-type="bibr" rid="article-18889.r15">[15]</xref>&#x000a0;Early detection and monitoring are crucial for managing cardiac fibromas in both pediatric and prenatal care settings.</p>
      </sec>
      <sec id="article-18889.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Cardiac fibromas predominantly affect the ventricles, with atrial fibromas being extremely rare. According to the latest WHO classification, nearly all cardiac fibromas originate in the interventricular septum, while the remaining cases occur in either the left or right ventricle. Fibromas in the left ventricle are 5 times as common as in the right ventricle.<xref ref-type="bibr" rid="article-18889.r12">[12]</xref>&#x000a0;One&#x000a0;hypothesis&#x000a0;suggests that tumor size increases with physiological cardiac growth and&#x000a0;ceases&#x000a0;to grow when the heart reaches maturity,&#x000a0;typically in individuals between the ages of 17 and 20. Consequently, as the heart undergoes somatic growth, the fibroma's relative size decreases compared to the cardiac mass,&#x000a0;although, unlike rhabdomyoma, fibromas never completely resolve.<xref ref-type="bibr" rid="article-18889.r16">[16]</xref></p>
        <p>Septal involvement and&#x000a0;diagnosis&#x000a0;before the age of 17 are associated with a poor prognosis. This can be attributed to younger patients having smaller hearts and a higher tumor-to-heart ratio compared to older individuals,&#x000a0;resulting in low cardiac output and adverse outcomes.<xref ref-type="bibr" rid="article-18889.r15">[15]</xref>&#x000a0;Fibromas affecting the interventricular septum&#x000a0;often lead to conduction&#x000a0;defects and arrhythmias. Unlike&#x000a0;cardiac rhabdomyoma, cardiac fibromas rarely regress spontaneously and often present with arrhythmias (32%),&#x000a0;primarily ventricular tachycardia (with a risk exceeding 50%), ventricular fibrillation, murmurs (20%), and abnormal chest x-ray (20%).<xref ref-type="bibr" rid="article-18889.r4">[4]</xref>&#x000a0;Although&#x000a0;coronary arteries are&#x000a0;typically unaffected, there have been reports of&#x000a0;large fibromas causing coronary compression.</p>
      </sec>
      <sec id="article-18889.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Cardiac fibromas appear as isolated, white, whorled tumors on gross examination. Histologically,&#x000a0;they lack a&#x000a0;capsule but are well-circumscribed. Composed of monomorphic fibroblasts exhibiting&#x000a0;minimal to&#x000a0;no atypia, these lesions may present with infiltrative margins into the cardiac muscle despite their macroscopic demarcation.<xref ref-type="bibr" rid="article-18889.r17">[17]</xref>&#x000a0;To establish continuity, distinguishing rare cases of multiple fibromas from peripheral outgrowths requires careful sectioning. The cellularity&#x000a0;typically&#x000a0;diminishes&#x000a0;with patient age, accompanied by increased collagen deposition. Mitotic activity is chiefly observed in infantile cases. Perivascular aggregates of lymphocytes and histiocytes, or sparse chronic inflammation at the&#x000a0;tumor-myocardium junction, may occasionally occur. Calcification is a&#x000a0;prevalent finding across all age groups affected by these fibromas.<xref ref-type="bibr" rid="article-18889.r18">[18]</xref><xref ref-type="bibr" rid="article-18889.r19">[19]</xref>&#x000a0;Immunohistochemistry reveals myofibroblastic&#x000a0;differentiation in the tumor cells, with positive staining for vimentin and smooth muscle actin. However, CD34, S100, and HMB45&#x000a0;exhibit negative staining, aiding the differential diagnosis.<xref ref-type="bibr" rid="article-18889.r18">[18]</xref><xref ref-type="bibr" rid="article-18889.r20">[20]</xref></p>
      </sec>
      <sec id="article-18889.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Cardiac fibromas may be asymptomatic. Typical presentations of cardiac fibromas, determined by the tumor location, include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Heart murmurs</p>
          </list-item>
          <list-item>
            <p>Arrhythmias</p>
          </list-item>
          <list-item>
            <p>Congestive heart failure</p>
          </list-item>
          <list-item>
            <p>Sudden death&#x000a0;<xref ref-type="bibr" rid="article-18889.r21">[21]</xref></p>
          </list-item>
        </list>
        <p>Nevoid basal cell carcinoma syndrome may present with lamellar or early calcification of the falx, odontogenic (jaw) keratocysts, palmar pits, plantar pits, and a predisposition for basal cell carcinomas. Characteristic facial features include macrocephaly, frontal bossing, and hypertelorism.&#x000a0;Skeletal anomalies, early childhood medulloblastoma, cleft lip/palate, and occasional occurrences&#x000a0;of ovarian fibromas in girls have also&#x000a0;been reported&#x000a0;in association with nevoid basal cell carcinoma syndrome.<xref ref-type="bibr" rid="article-18889.r22">[22]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-18889.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Fibromas are noncontractile solid masses that can appear in the ventricular wall and are detectable on echocardiography. Computed tomography (CT) scans typically depict them as homogeneous masses with soft-tissue attenuation, often revealing calcifications. On T1-weighted magnetic resonance images (MRI), fibromas appear as well-circumscribed isointense or hyperintense regions&#x000a0;within the myocardium, while they appear hypointense on T2-weighted MRI. Fibromas typically do not enhance&#x000a0;following&#x000a0;intravenous contrast administration.</p>
        <p>Histology is not always required for diagnosis in the presence of clinical phenotype and MRI findings. Electrocardiograms (ECG) of most patients with fibroma reveal&#x000a0;T-wave abnormalities, with VT morphologies largely&#x000a0;consistent with an origin near the tumor site. In adults, fibromas may&#x000a0;present as fixed defects on myocardial perfusion imaging.<xref ref-type="bibr" rid="article-18889.r14">[14]</xref></p>
      </sec>
      <sec id="article-18889.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Given&#x000a0;the&#x000a0;rarity of cardiac fibromas, which occur in 1 in 280,000 births, the&#x000a0;optimal clinical management remains unclear,&#x000a0;presenting a challenge for pediatric cardiologists. The literature suggests&#x000a0;various&#x000a0;management strategies, including surgical resection, single ventricle palliation, cardiac transplant, and even conservative treatment with antiarrhythmic medications.</p>
        <p>Implanting a defibrillator to prevent malignant arrhythmias in infants carries a substantial risk of complications. A defibrillator should be considered only after ruling out other options and discussing the risks and benefits with the parents. One common&#x000a0;approach involves placing an endocardial defibrillator lead around the heart&#x02019;s posterior in the epicardial space, coupled with epicardial pace/sense leads. Alternatively, another option is&#x000a0;to utilize epicardial pace/sense leads and tunnel an endocardial defibrillator lead along the intercostal space. However, with an epicardial defibrillator, the risk of lead fracture is significant, with a reported 5-year failure rate of 50%.<xref ref-type="bibr" rid="article-18889.r23">[23]</xref></p>
        <p>Medical management with amiodarone and beta-blockers has shown efficacy, particularly in small and apically located fibromas. These fibromas often respond well to antiarrhythmic medications, potentially&#x000a0;eliminating the need for&#x000a0;defibrillators. Surgical resection has demonstrated&#x000a0;curative potential,&#x000a0;eliminating&#x000a0;the&#x000a0;necessity for defibrillators and long-term antiarrhythmic medications.&#x000a0;This approach is also&#x000a0;viable for large fibromas with&#x000a0;favorable&#x000a0;outcomes. However, a notable&#x000a0;challenge is the&#x000a0;scarcity of cardiac centers with&#x000a0;expertise in fibroma removal.</p>
        <p>Surgery is typically recommended in individuals between the ages of 1 and 3, considering factors&#x000a0;such as arrhythmia severity, medication tolerance, defibrillation lead integrity, and&#x000a0;symptomatic presentation. Although the location and size of the tumor can complicate surgical intervention, morbidity and mortality rates remain low.&#x000a0;Due to the limited number of patients, comparative effectiveness studies on these treatments are challenging.<xref ref-type="bibr" rid="article-18889.r23">[23]</xref></p>
        <p>In patients with tumors&#x000a0;not&#x000a0;amendable&#x000a0;to&#x000a0;resection due to their size and extensive involvement of cardiac structures, several&#x000a0;documented&#x000a0;cases of single ventricle palliation have emerged. For instance, in&#x000a0;a case&#x000a0;involving a&#x000a0;large&#x000a0;right ventricle fibroma, single ventricle palliation was&#x000a0;achieved through&#x000a0;balloon atrial&#x000a0;septostomy&#x000a0;and the placement of a systemic-to-pulmonary shunt. This approach facilitates unobstructed venous return to the left atrium and left ventricle, supporting systemic and pulmonary circulation. Such ventricular palliation techniques,&#x000a0;among others, have served as a&#x000a0;bridge to heart transplantation for patients with inoperable cardiac fibromas.<xref ref-type="bibr" rid="article-18889.r24">[24]</xref></p>
      </sec>
      <sec id="article-18889.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnoses for cardiac fibromas include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cardiac rhabdomyoma: The presence of calcification&#x000a0;aids in&#x000a0;distinguishing cardiac fibroma from rhabdomyoma.</p>
          </list-item>
          <list-item>
            <p>Myxomas:&#x000a0;Unlike myxomas, cardiac fibromas are intramural, predominantly ventricular, and&#x000a0;lack a stalk, while myxomas are selectively atrial.</p>
          </list-item>
          <list-item>
            <p>Teratomas</p>
          </list-item>
          <list-item>
            <p>Lipomas:&#x000a0;In contrast to fibromas, which are intramural and solitary, lipomas are&#x000a0;typically epicardial, multiple, and encapsulated primary cardiac tumors.</p>
          </list-item>
          <list-item>
            <p>Hemangiomas:&#x000a0;These typically exhibit a rich vascular stroma, a feature absent in fibromas.&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18889.s11" sec-type="Surgical Oncology">
        <title>Surgical Oncology</title>
        <p>Stereotactic radiosurgery has been described as a management step for ventricular arrhythmias in unresectable cardiac fibromas. However, it is not universally recognized as a treatment.<xref ref-type="bibr" rid="article-18889.r25">[25]</xref></p>
      </sec>
      <sec id="article-18889.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>In infancy, cardiac fibromas that are not surgically resectable&#x000a0;due to their&#x000a0;size and extensive myocardial infiltration&#x000a0;often carry a poor prognosis, potentially necessitating defibrillator implantation or cardiac transplantation.<xref ref-type="bibr" rid="article-18889.r26">[26]</xref>&#x000a0;Conversely, resectable tumors, even if incompletely removed, have a&#x000a0;favorable prognosis. In one study, the median survival of patients with cardiac fibromas&#x000a0;following successful surgery was reported to be 27 years.<xref ref-type="bibr" rid="article-18889.r27">[27]</xref></p>
      </sec>
      <sec id="article-18889.s13" sec-type="Complications">
        <title>Complications</title>
        <p>Untreated cardiac fibromas&#x000a0;elevate&#x000a0;the risk of fatality, primarily due to the potential development of lethal ventricular arrhythmias. Early detection and appropriate medical intervention are crucial in managing the condition and reducing the associated risks.</p>
      </sec>
      <sec id="article-18889.s14" sec-type="Consultations">
        <title>Consultations</title>
        <p>Individuals newly diagnosed with nevoid basal cell carcinoma syndrome should&#x000a0;be promptly referred to dermatologists, pediatricians, and geneticists for comprehensive evaluation. According to guidelines, obstetrics-gynecology, and psychology evaluations are recommended to&#x000a0;facilitate cancer surveillance and to ensure early identification of potential complications.<xref ref-type="bibr" rid="article-18889.r8">[8]</xref></p>
      </sec>
      <sec id="article-18889.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients diagnosed with nevoid basal cell carcinoma syndrome, which occurs in a notable percentage of individuals with cardiac fibromas, should be educated regarding the associated risks. Due to their&#x000a0;predisposition&#x000a0;to basal&#x000a0;cell&#x000a0;carcinoma, these patients are strongly advised to apply sunscreen, limit sun exposure, and avoid ionizing radiation.</p>
      </sec>
      <sec id="article-18889.s16" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Key facts to keep in mind about&#x000a0;cardiac fibroma&#x000a0;are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cardiac fibromas are rare primary cardiac tumors, accounting for a small percentage of cardiac neoplasms.</p>
          </list-item>
          <list-item>
            <p>They often present in infancy or childhood and can be asymptomatic or present with symptoms related to intracardiac obstruction, arrhythmias, or thromboembolic events.</p>
          </list-item>
          <list-item>
            <p>Cardiac fibromas are typically intramural and most commonly involve the interventricular septum, although they can occur in other cardiac structures.</p>
          </list-item>
          <list-item>
            <p>Diagnosis is typically made through imaging modalities such as echocardiography, CT scans, or MRI. Histological examination may be necessary for confirmation.</p>
          </list-item>
          <list-item>
            <p>Treatment options include surgical resection, medical management with antiarrhythmic medications, and, in some cases, cardiac transplantation. The choice of management depends on factors such as tumor size, location, and the patient's clinical condition.</p>
          </list-item>
          <list-item>
            <p>Cardiac fibromas are intramural and typically do not embolize or regress. While they may cease growth, as the heart matures, the tumor-to-heart size ratio may improve, potentially obviating the need for surgery. Thus, a conservative watch-and-wait approach may be suitable for symptomatic pediatric patients with stable conditions and no risk of sudden cardiac death.</p>
          </list-item>
          <list-item>
            <p>The prognosis varies depending on factors such as tumor size, location, and response to treatment. Resectable tumors generally have a more favorable prognosis compared to unresectable ones.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18889.s17" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Given its wide phenotypic variations, nevoid basal cell carcinoma syndrome poses a diagnostic challenge, necessitating a high index of suspicion for timely recognition. In sporadic cases, diagnosing nevoid basal cell carcinoma syndrome in proband should&#x000a0;prompt genetic testing of other family members. Management involves appropriate&#x000a0;cancer screening and preventive measures. This includes regular screening for basal cell carcinoma, with&#x000a0;recommendations for&#x000a0;sunscreen application, sun exposure reduction, and avoidance of ionizing radiation. Additionally, early childhood medulloblastoma warrants attention, with annual brain MRI with contrast recommended for children younger than 8 years.</p>
        <p>The diagnosis of cardiac fibroma,&#x000a0;although rare as an initial presentation, should prompt an evaluation of nevoid basal cell carcinoma syndrome and a&#x000a0;thorough assessment of the patient&#x02019;s medical and family history. As&#x000a0;previously noted,&#x000a0;individuals diagnosed with nevoid basal cell carcinoma syndrome&#x000a0;face an&#x000a0;increased risk of both benign and malignant neoplasms at an early stage. Therefore, experts&#x000a0;advocate for coordinated multispecialty care&#x000a0;to ensure&#x000a0;comprehensive surveillance of these patients.<xref ref-type="bibr" rid="article-18889.r28">[28]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-18889.s18">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18889&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18889">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/heart-health/cardiac-fibroma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=18889">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/18889/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=18889">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-18889.s19">
        <title>References</title>
        <ref id="article-18889.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nadas</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Ellison</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Cardiac tumors in infancy.</article-title>
            <source>Am J Cardiol</source>
            <year>1968</year>
            <month>Mar</month>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>363</fpage>
            <page-range>363-6</page-range>
            <pub-id pub-id-type="pmid">4866645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simcha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wells</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Tynan</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Waterston</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Primary cardiac tumours in childhood.</article-title>
            <source>Arch Dis Child</source>
            <year>1971</year>
            <month>Aug</month>
            <volume>46</volume>
            <issue>248</issue>
            <fpage>508</fpage>
            <page-range>508-14</page-range>
            <pub-id pub-id-type="pmid">5565462</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Isaacs</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Fetal and neonatal hepatic tumors.</article-title>
            <source>J Pediatr Surg</source>
            <year>2007</year>
            <month>Nov</month>
            <volume>42</volume>
            <issue>11</issue>
            <fpage>1797</fpage>
            <page-range>1797-803</page-range>
            <pub-id pub-id-type="pmid">18022426</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miyake</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Del Nido</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Alexander</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Cecchin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Berul</surname>
                <given-names>CI</given-names>
              </name>
              <name>
                <surname>Triedman</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Geva</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>EP</given-names>
              </name>
            </person-group>
            <article-title>Cardiac tumors and associated arrhythmias in pediatric patients, with observations on surgical therapy for ventricular tachycardia.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2011</year>
            <month>Oct</month>
            <day>25</day>
            <volume>58</volume>
            <issue>18</issue>
            <fpage>1903</fpage>
            <page-range>1903-9</page-range>
            <pub-id pub-id-type="pmid">22018302</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burke</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Rosado-de-Christenson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Templeton</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Virmani</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Cardiac fibroma: clinicopathologic correlates and surgical treatment.</article-title>
            <source>J Thorac Cardiovasc Surg</source>
            <year>1994</year>
            <month>Nov</month>
            <volume>108</volume>
            <issue>5</issue>
            <fpage>862</fpage>
            <page-range>862-70</page-range>
            <pub-id pub-id-type="pmid">7967668</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Becker</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Primary heart tumors in the pediatric age group: a review of salient pathologic features relevant for clinicians.</article-title>
            <source>Pediatr Cardiol</source>
            <year>2000</year>
            <season>Jul-Aug</season>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>317</fpage>
            <page-range>317-23</page-range>
            <pub-id pub-id-type="pmid">10865004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gorlin</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Nevoid basal cell carcinoma (Gorlin) syndrome.</article-title>
            <source>Genet Med</source>
            <year>2004</year>
            <season>Nov-Dec</season>
            <volume>6</volume>
            <issue>6</issue>
            <fpage>530</fpage>
            <page-range>530-9</page-range>
            <pub-id pub-id-type="pmid">15545751</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ritter</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Granquist</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Iyer</surname>
                <given-names>VR</given-names>
              </name>
              <name>
                <surname>Izumi</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Cardiac Fibroma with Ventricular Tachycardia: An Unusual Clinical Presentation of Nevoid Basal Cell Carcinoma Syndrome.</article-title>
            <source>Mol Syndromol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>219</fpage>
            <page-range>219-223</page-range>
            <pub-id pub-id-type="pmid">30140199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bresler</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Padwa</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Granter</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome).</article-title>
            <source>Head Neck Pathol</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>119</fpage>
            <page-range>119-24</page-range>
            <pub-id pub-id-type="pmid">26971503</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Menon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dentel</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Sanil</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lawrence</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Cardiac Fibroma with Asymptomatic Ventricular Arrhythmia in an Adolescent with Gorlin's Syndrome.</article-title>
            <source>J Pediatr Genet</source>
            <year>2023</year>
            <month>Jun</month>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>171</fpage>
            <page-range>171-174</page-range>
            <pub-id pub-id-type="pmid">37090839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lo Muzio</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Nevoid basal cell carcinoma syndrome (Gorlin syndrome).</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2008</year>
            <month>Nov</month>
            <day>25</day>
            <volume>3</volume>
            <fpage>32</fpage>
            <pub-id pub-id-type="pmid">19032739</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nicholson</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Tsao</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Beasley</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Borczuk</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Brambilla</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Dacic</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kerr</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Lantuejoul</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Noguchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Papotti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rekhtman</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Scagliotti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>van Schil</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sholl</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yatabe</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yoshida</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Travis</surname>
                <given-names>WD</given-names>
              </name>
            </person-group>
            <article-title>The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015.</article-title>
            <source>J Thorac Oncol</source>
            <year>2022</year>
            <month>Mar</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>362</fpage>
            <page-range>362-387</page-range>
            <pub-id pub-id-type="pmid">34808341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sheppard</surname>
                <given-names>MN</given-names>
              </name>
            </person-group>
            <article-title>Pathological study of primary cardiac and pericardial tumours in a specialist UK Centre: surgical and autopsy series.</article-title>
            <source>Cardiovasc Pathol</source>
            <year>2010</year>
            <season>Nov-Dec</season>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>343</fpage>
            <page-range>343-52</page-range>
            <pub-id pub-id-type="pmid">19747857</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pittman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sethi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Flavell</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Pampaloni</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Cardiac Fibroma: An Uncommon Cause of a Fixed Defect on Myocardial Perfusion Imaging.</article-title>
            <source>Clin Nucl Med</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>43</volume>
            <issue>2</issue>
            <fpage>e56</fpage>
            <page-range>e56-e58</page-range>
            <pub-id pub-id-type="pmid">29215416</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Torimitsu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nemoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wakayama</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Okubo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yokose</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kitahara</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ozawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nakayama</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shinozaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sasai</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ishiwatari</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Takuma</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shibuya</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Literature survey on epidemiology and pathology of cardiac fibroma.</article-title>
            <source>Eur J Med Res</source>
            <year>2012</year>
            <month>Mar</month>
            <day>27</day>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>5</fpage>
            <pub-id pub-id-type="pmid">22472419</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Isaacs</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Fetal and neonatal cardiac tumors.</article-title>
            <source>Pediatr Cardiol</source>
            <year>2004</year>
            <season>May-Jun</season>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>252</fpage>
            <page-range>252-73</page-range>
            <pub-id pub-id-type="pmid">15360117</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grunau</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Leipsic</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Sellers</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Seidman</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Cardiac Fibroma in an Adult AIRP Best Cases in Radiologic-Pathologic Correlation.</article-title>
            <source>Radiographics</source>
            <year>2018</year>
            <season>Jul-Aug</season>
            <volume>38</volume>
            <issue>4</issue>
            <fpage>1022</fpage>
            <page-range>1022-2026</page-range>
            <pub-id pub-id-type="pmid">29995616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Humez</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gibier</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Recher</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Leteurtre</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Leroy</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Devisme</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>[Cardiac fibroma: A rare cause of sudden child death].</article-title>
            <source>Ann Pathol</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>35</volume>
            <issue>5</issue>
            <fpage>445</fpage>
            <page-range>445-8</page-range>
            <pub-id pub-id-type="pmid">26372501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Freedom</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>MacDonald</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Selected aspects of cardiac tumors in infancy and childhood.</article-title>
            <source>Pediatr Cardiol</source>
            <year>2000</year>
            <season>Jul-Aug</season>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>299</fpage>
            <page-range>299-316</page-range>
            <pub-id pub-id-type="pmid">10865003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cronin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lynch</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Parsons</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cardiac fibroma presenting as sudden unexpected death in an adolescent.</article-title>
            <source>Forensic Sci Med Pathol</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>647</fpage>
            <page-range>647-50</page-range>
            <pub-id pub-id-type="pmid">25027414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zheng</surname>
                <given-names>XJ</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Left ventricle primary cardiac fibroma in an adult: A case report.</article-title>
            <source>Oncol Lett</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>5463</fpage>
            <page-range>5463-5465</page-range>
            <pub-id pub-id-type="pmid">30250618</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Evans</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Howard</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Giblin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Clancy</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Huson</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Lalloo</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service.</article-title>
            <source>Am J Med Genet A</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>152A</volume>
            <issue>2</issue>
            <fpage>327</fpage>
            <page-range>327-32</page-range>
            <pub-id pub-id-type="pmid">20082463</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jones</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Ramcharan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chaudhari</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bhole</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mcleod</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sadagopan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Uzun</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Parry</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Till</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McMahon</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Stuart</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Ventricular fibromas in children, arrhythmia risk, and outcomes: A multicenter study.</article-title>
            <source>Heart Rhythm</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>15</volume>
            <issue>10</issue>
            <fpage>1507</fpage>
            <page-range>1507-1512</page-range>
            <pub-id pub-id-type="pmid">29906523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Waller</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Bradley</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Crumbley</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Wiles</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>McQuinn</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>Cardiac fibroma in an infant: single ventricle palliation as a bridge to heart transplantation.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2003</year>
            <month>Apr</month>
            <volume>75</volume>
            <issue>4</issue>
            <fpage>1306</fpage>
            <page-range>1306-8</page-range>
            <pub-id pub-id-type="pmid">12683582</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haskova</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Peichl</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pirk</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cvek</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Neuwirth</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kautzner</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Stereotactic radiosurgery as a treatment for recurrent ventricular tachycardia associated with cardiac fibroma.</article-title>
            <source>HeartRhythm Case Rep</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>44</fpage>
            <page-range>44-47</page-range>
            <pub-id pub-id-type="pmid">30693205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Padalino</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Vida</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Boccuzzo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tonello</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sarris</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Berggren</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Comas</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Di Carlo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Di Donato</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Ebels</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hraska</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Gaynor</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Metras</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pretre</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pozzi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rubay</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sairanen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Schreiber</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Maruszewski</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Basso</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stellin</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Surgery for primary cardiac tumors in children: early and late results in a multicenter European Congenital Heart Surgeons Association study.</article-title>
            <source>Circulation</source>
            <year>2012</year>
            <month>Jul</month>
            <day>03</day>
            <volume>126</volume>
            <issue>1</issue>
            <fpage>22</fpage>
            <page-range>22-30</page-range>
            <pub-id pub-id-type="pmid">22626745</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elbardissi</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Dearani</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Daly</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Mullany</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Orszulak</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Puga</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Schaff</surname>
                <given-names>HV</given-names>
              </name>
            </person-group>
            <article-title>Survival after resection of primary cardiac tumors: a 48-year experience.</article-title>
            <source>Circulation</source>
            <year>2008</year>
            <month>Sep</month>
            <day>30</day>
            <volume>118</volume>
            <issue>14 Suppl</issue>
            <fpage>S7</fpage>
            <page-range>S7-15</page-range>
            <pub-id pub-id-type="pmid">18824772</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18889.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Foulkes</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Kamihara</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>DGR</given-names>
              </name>
              <name>
                <surname>Brugi&#x000e8;res</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bourdeaut</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Molenaar</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Brodeur</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Diller</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome.</article-title>
            <source>Clin Cancer Res</source>
            <year>2017</year>
            <month>Jun</month>
            <day>15</day>
            <volume>23</volume>
            <issue>12</issue>
            <fpage>e62</fpage>
            <page-range>e62-e67</page-range>
            <pub-id pub-id-type="pmid">28620006</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
